Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Saarinen

Showing results (261-270 of 309) with videos related to

Pageof 31
Sort By:
European Journal of Pediatrics|November 19, 1997
Growth impairment and growth hormone therapy in children treated for malignant brain tumoursI Ilveskoski, U M Saarinen, T Wiklund, et al.
Tropical Medicine and Parasitology : Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft Fur Technische Zusammenarbeit (GTZ)|March 1, 1988
Malaria prophylaxis with proguanil to Namibian refugee children in AngolaM Saarinen, E Thoren, N Iyambo, et al.
Neuropediatrics|June 1, 1996
Neuropsychologic late effects in children with malignant brain tumors treated with surgery, radiotherapy and "8 in 1" chemotherapyI Ilveskoski, H Pihko, T Wiklund, et al.
Pediatric Hematology and Oncology|February 24, 2001
Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-upJ Kanerva, M I Tiirikainen, A Mäkipernaa, et al.
Leukemia|October 10, 1998
Comparative genomic hybridization in childhood acute lymphoblastic leukemiaM L Larramendy, T Huhta, K Vettenranta, et al.
Schizophrenia Research|November 29, 2018
Body mass index trajectories in childhood and adolescence - Risk for non-affective psychosisElina Sormunen, Maiju M Saarinen, Raimo K R Salokangas, et al.
Leukemia & Lymphoma|April 18, 2012
MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic toolsNeda Mosakhani, Virinder Kaur Sarhadi, Anu Usvasalo, et al.
Pediatric Blood & Cancer|January 31, 2004
Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusionJukka Kanerva, Ulla M Saarinen-Pihkala, Tarja Niini, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 17, 2009
Dietary and lifestyle counselling reduces the clustering of overweight-related cardiometabolic risk factors in adolescentsM Hakanen, H Lagström, K Pahkala, et al.
Plos One|April 5, 2014
Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer modelEmrah Yatkin, Lauri Polari, Teemu D Laajala, et al.
Pageof 31

Showing results (261-270 of 309) with videos related to

Sort By:
Pageof 31
European Journal of Pediatrics|November 19, 1997
Growth impairment and growth hormone therapy in children treated for malignant brain tumoursI Ilveskoski, U M Saarinen, T Wiklund, et al.
Tropical Medicine and Parasitology : Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft Fur Technische Zusammenarbeit (GTZ)|March 1, 1988
Malaria prophylaxis with proguanil to Namibian refugee children in AngolaM Saarinen, E Thoren, N Iyambo, et al.
Neuropediatrics|June 1, 1996
Neuropsychologic late effects in children with malignant brain tumors treated with surgery, radiotherapy and "8 in 1" chemotherapyI Ilveskoski, H Pihko, T Wiklund, et al.
Pediatric Hematology and Oncology|February 24, 2001
Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-upJ Kanerva, M I Tiirikainen, A Mäkipernaa, et al.
Leukemia|October 10, 1998
Comparative genomic hybridization in childhood acute lymphoblastic leukemiaM L Larramendy, T Huhta, K Vettenranta, et al.
Schizophrenia Research|November 29, 2018
Body mass index trajectories in childhood and adolescence - Risk for non-affective psychosisElina Sormunen, Maiju M Saarinen, Raimo K R Salokangas, et al.
Leukemia & Lymphoma|April 18, 2012
MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic toolsNeda Mosakhani, Virinder Kaur Sarhadi, Anu Usvasalo, et al.
Pediatric Blood & Cancer|January 31, 2004
Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusionJukka Kanerva, Ulla M Saarinen-Pihkala, Tarja Niini, et al.
Acta Paediatrica (Oslo, Norway : 1992)|December 17, 2009
Dietary and lifestyle counselling reduces the clustering of overweight-related cardiometabolic risk factors in adolescentsM Hakanen, H Lagström, K Pahkala, et al.
Plos One|April 5, 2014
Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer modelEmrah Yatkin, Lauri Polari, Teemu D Laajala, et al.
Pageof 31